American Association of Clinical Endocrinology Consensus Statement on Management of Multiple Endocrine Neoplasia Type 1
Methodological detailsTask force of 9 members (endocrinology, surgery, medical oncology, genetics, patient advocacy); consensus defined as ≤1 dissenting vote, significant majority as ≥75%; statements based on literature review
- Task force of 9 members (endocrinology, surgery, medical oncology, genetics, patient advocacy); consensus defined as ≤1 dissenting vote, significant majority as ≥75%; statements based on literature review
Scope
As issued by the authors
Diagnosis, management and surveillance of MEN1 and associated tumors (parathyroid, pituitary, GEP-NET, other), and indications for MEN1 genetic testing
Original publication
American Association of Clinical Endocrinology Consensus Statement on Management of Multiple Endocrine Neoplasia Type 1. Endocr Pract. Published 26 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →